Brickell Biotech is a clinical-stage pharmaceutical company focused on the development of innovative and differentiated therapeutics for the treatment of skin diseases. Under this collaboration, Brickell will continue the research and development of Orca's RORγ inhibitors, initially targeting the topical treatment of psoriasis.
Become A Partner
We are open to partnering with other organization. If you or your organization is interested in partnering with Orca Pharmaceuticals, please contact us via the form below.